GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (STU:CJH) » Definitions » Change In Other Working Capital

CanSino Biologics (STU:CJH) Change In Other Working Capital : €0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Change In Other Working Capital?

CanSino Biologics's Change In Other Working Capital for the quarter that ended in Dec. 2024 was €0.00 Mil. It means CanSino Biologics's Other Working Capital stayed the same from Jun. 2024 to Dec. 2024 .

CanSino Biologics's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €-5.00 Mil. It means CanSino Biologics's Other Working Capital declined by €5.00 Mil from Dec. 2023 to Dec. 2024 .

CanSino Biologics Change In Other Working Capital Historical Data

The historical data trend for CanSino Biologics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Change In Other Working Capital Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only 19.00 164.09 -54.39 -29.66 -5.00

CanSino Biologics Quarterly Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CanSino Biologics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanSino Biologics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (STU:CJH) » Definitions » Change In Other Working Capital
Comparable Companies
HKSE:00570 HKSE:01558 HKSE:02005 HKSE:01681 HKSE:00460 HKSE:02186 HKSE:03613 HKSE:01349 HKSE:02877 HKSE:02561 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
CASBF:USA 06185:Hong Kong 688185:China
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
Website
https://www.cansinotech.com
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

CanSino Biologics Headlines

No Headlines